［1］Du FH,Min XH,Mei XD.Application of targeted therapy drugs for lung adenocarcinoma and drug resistance mechanism ［J］.Journal of Clinical Pulmonary Diseases,2018,23(01):168-172.［杜凤华,闵旭红,梅晓冬.肺腺癌靶向治疗药物的应用及耐药机制［J］.临床肺科杂志,2018,23(01):168-172.］
［2］Chen H,Laba JM,Boldt RG,et al.Stereotactic ablative radiation therapy versus surgery in early lung cancer:A meta-analysis of propensity score studies［J］.Int J Radiat Oncol Biol Phys,2018,101(01):186-194.
［3］Zhou CC.Palliative care for advanced lung cancer ［J］.China Journal of Respiratory and Critical Care,2005,4(03):177-178.［周彩存.晚期肺癌的姑息治疗［J］.中国呼吸与危重监护杂志,2005,4(03):177-178.］
［4］Hua XH,Zhang RX,Li Y.Research on gene mutation of EGFR gene and molecular targeted therapy for non-small cell lung cancer［J］.Journal of Clinical Pulmonary Science,2012,17(01):117-119.［华胸怀,张瑞祥,李印.EGFR基因突变与非小细胞肺癌分子靶向治疗的研究现况［J］.临床肺科杂志,2012,17(01):117-119.］
［5］Robinson AG,Young K,Balchin K,et al.Reasons for palliative treatments in stage III non-small-cell lung cancer:what contribution is made by time-dependent changes in tumour or patient status［J］?Current Oncology,2015,22(06):399-404.
［6］Liu J,Cheng Y.The significance of palliative treatment in the comprehensive treatment of advanced lung cancer［C］.2014 National Cancer Rehabilitation and Palliative Medicine Conference,2014.［柳菁菁,程颖.姑息治疗在晚期肺癌综合治疗中的意义［C］.2014全国癌症康复与姑息医学大会,2014.］
［7］Aguirrebravo AN,Sampallopedroza R.Phonoaudiology in palliative care［J］.Rev Fac Med,2015,63(02):289-300.
［8］Peng X,Wen Q,Mao F,et al.Research progress on tumor palliative treatment ［J］.Journal of Nursing Management,2015,15(07):488-490.［彭昕,闻曲,毛菲,等.肿瘤姑息治疗研究进展［J］.护理管理杂志,2015,15(07):488-490.］
［9］Ploenes T,Lopezpastorini A,Ludwig C,et al.F-088 surgical approach is superior to palliative treatment in oligometastatic lung cancer［J］.European Surgery,2016,48(06):1-5.
［10］Salvati M,Tropeano MP,Maiola V,et al.Multiple brain metastases:a surgical series and neurosurgical perspective［J］.Neurological Sciences,2018,39(04):671-677.
［11］Wang CD,Gong Q,Zhang LJ,et al.Progress in palliative treatment of malignant tumor［J］.Chinese Cancer,2012,21(03):206-210.［王存德,龚泉,张利娟,等.恶性肿瘤姑息治疗的进展［J］.中国肿瘤,2012,21(03):206-210.］
［12］Zhang FJ.The role of palliative chemotherapy in patients with lung cancer ［J］.Chinese Medicine Guide,2016,14(02):106-107.［张富娟.肺癌患者实施姑息性化疗对可延长生存期的作用［J］.中国医药指南,2016,14(02):106-107.］
［13］Hotwani C,Agarwal JP,Prabhash K,et al.Palliative thoracic radiotherapy in advanced lung cancer:A single institution experience［J］.Indian Journal of Cancer,2017,54(01):262-266.
［14］Gu X,Cheng W,Chen M,et al.Timing of referral to inpatient palliative care services for advanced cancer patients and earlier referral predictors in mainland China［J］.Palliative & Supportive Care,2016,14(05):503-509.
［15］Kelly M,O'Brien KM,Lucey M,et al.Indicators for early assessment of palliative care in lung cancer patients:A population study using linked health data［J］.Bmc Palliative Care,2018,17(01):37.
［16］Zhong Guocheng,Wu Chaoqun,Feng Huaizhi,et al.Clinical analysis on the treatment of small cell lung cancer in patients with a wide range of small cell lung cancer combined with CIK of DC tumor ［J］.Modern Oncology,2014,22(11):2593-2596.［钟国成,吴超群,冯怀志,等.DC瘤苗联合CIK姑息治疗广泛期小细胞肺癌的临床分析［J］.现代肿瘤医学,2014,22(11):2593-2596.］
［17］Yin DF.The present situation and prospect of the treatment of malignant tumor by combining traditional Chinese and western medicine ［J］.Journal of Practical Chinese Medicine,2012,26(10):1-4.［殷东风.中西医结合姑息治疗恶性肿瘤现状及展望［J］.实用中医内科杂志,2012,26(10):1-4.］
［18］Rao J.Research on the current situation of treatment of end-stage cancer patients and related causes ［D］.Huazhong University of Science and Technology,2015.［饶洁.终末期癌症患者治疗的现状调查和相关原因探索［D］.华中科技大学,2015.］
［19］Wang YL.Clinical evaluation of 40 cases of palliative care for multiple primary cancer patients ［J］.China Health Standards Management,2017,8(21):35-37.［王轶霖.多原发癌40例姑息治疗多学科会诊临床评价［J］.中国卫生标准管理,2017,8(21):35-37.］
［20］Shin J,Temel J.Integrating palliative care:When and how［J］?Current Opinion in Pulmonary Medicine,2013,19(04):344-349.
［21］Niu SL,Lu YQ.Palliative care for patients with advanced lung cancer［J］.Chinese Primary Medicine,2015,22(22):3496-3499.［牛素玲,吕英谦.晚期肺癌患者的姑息治疗［J］.中国基层医药,2015,22(22):3496-3499.］
［22］Ferrell BR,Temel JS,Temin S,et al.Integration of palliative care into standard oncology care:American society of clinical oncology clinical practice guideline update［J］.Journal of Oncology Practice,2017,35(01):96-112.
［23］Lin JT,Lin LZ.Clinical advantages of palliative treatment and traditional chinese medicine［J］.Journal of Traditional Chinese Medicine,2015,56(14):1198-1201.［林洁涛,林丽珠.肿瘤的姑息治疗与中医药临床优势［J］.中医杂志,2015,56(14):1198-1201.］
［24］Wei XP,Ma XD,Jiang W,et al.Analysis of low-dose spiral CT screening in high-risk groups of community lung cancer ［J］.Shanghai Medicine & Pharmaceuticals,2018,39(02):47-49.［魏新萍,马学东,江威,等.社区肺癌高危人群低剂量螺旋CT筛查结果分析［J］.上海医药,2018,39(02):47-49.］
［25］Lin CY.The efficacy and safety of single-operating-perforated TV thorax in the treatment of patients with early lung cancer ［J］.Clinical Pulmonary Medicine,2015,20(04):630-633.［林称意.单操作孔电视胸腔根治术在治疗早期肺癌患者的有效性及安全性［J］.临床肺科杂志,2015,20(04):630-633.］
［26］Lutz S,Norrell R,Bertucio C,et al.Symptom frequency and severity in patients with metastatic or locally recurrent lung cancer:A prospective study using the lung cancer symptom scale in a community hospital［J］.Journal of Palliative Medicine,2001,4(02):157-165.
［27］Duan JC,Wan R,Shen JQ,et al.The clinical features and prognosis of pancreatic metastasis in lung cancer ［J］.Journal of Chinese Lung Cancer,2017,20(08):511-515.［段建春,万蕊,沈剑钦,等.肺癌胰腺转移的临床特点及预后分析［J］.中国肺癌杂志,2017,20(08):511-515.］
［28］Janssens A,Teugels L,Kohl S,et al.Practical tools for implementing early palliative care in advanced lung cancer［J］.European Respiratory Journal,2016,47(03):1010-1012.
［29］Lu JW,Xu L.The establishment and advantage of the concept of palliative care for cancer of cancer ［J］.Clinical Research of Chinese Medicine,2013,5(01):110-112.［鹿竞文,徐力.肿瘤中医姑息治疗概念的建立及其优势探讨［J］.中医临床研究,2013,5(01):110-112.］
［30］Bakitas MA,Tosteson TD,Li Z,et al.Early versus delayed initiation of concurrent palliative oncology care:Patient outcomes in the ENABLE III randomized controlled trial［J］.Journal of Clinical Oncology,2015,33(13):1438-1445.
［31］Han SL,Gao J,Hu Y.The clinical significance of early palliative treatment in IV period lung cancer［J］.Journal of Clinical Lung,2011,16(12):1961-1961.［韩锁利,高静,胡岩.早期姑息治疗在Ⅳ期肺癌中的临床意义［J］.临床肺科杂志,2011,16(12):1961-1961.］
［32］Temel JS,Greer JA,Muzikansky A,et al.Early palliative care for patients with metastatic non-small-cell lung cancer［J］.N Engl J Med,2010,363(08):733-742.
［33］Zimmermann C,Swami N,Krzyzanowska M,et al.Early palliative care for patients with advanced cancer:A cluster-randomised controlled trial［J］.Lancet,2014,383(9930):1721-1730.
［34］Eljawahri A,Greer JA,Pirl WF,et al.Effects of early integrated palliative care on caregivers of patients with lung and gastrointestinal cancer:A randomized clinical trial［J］.Oncologist,2017,22(12):1528-1534.
［35］Dionneodom JN,Azuero A,Lyons KD,et al.Benefits of early versus delayed palliative care to informal family caregivers of patients with advanced cancer:Outcomes from the ENABLE III randomized controlled trial［J］.Journal of Clinical Oncology,2015,33(13):1446-1452.
［36］Nieder C,Tollali T,Haukland E,et al.Impact of early palliative interventions on the outcomes of care for patients with non-small cell lung cancer［J］.Supportive Care in Cancer,2016,24(10):1-7.